5 results
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
III Non–Small-Cell ... Lung Cancer - Progression-free ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
ALK-Positive Non–Small-Cell ... Lung Cancer #EBM ... #Honc #Alectinib ... VisualAbstract #NEJM
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
IgG4-Related Disease ... biliary, renal, lung ... concentration PET-CT ... increased IgG4+ cells ... #diagnosis #management
Squamous-Cell Carcinoma of the Lung- ...Physical examination revealed decreased air entry in the base of the
Squamous-Cell Carcinoma ... of the Lung- .. ... indicated stage IV disease ... #NEJM #clinical ... #radiology #CT #
Langerhans Cell Histiocytosis (LCH)

Granulomatous Lesions comprising langerin-positive histiocytes and an inflammatory infiltrate can arise in virtually
the bones, skin, lungs ... Birbeck granules (EM ... Imaging: X-rays, CT ... PET-CT / MRI: Staging ... Histiocytosis #Diagnosis #Management